Novo Nordisk’s quiet entry into the year of Alzheimer’s

Novo Nordisk’s quiet entry into the year of Alzheimer’s

Source: 
EP Vantage
snippet: 

An upcoming study could show whether diabetes drugs like Novo’s Victoza might have an effect on slowing cognitive decline.